The tumor suppressor p16Ink4a regulates T lymphocyte survival

Oncogene

Volumn 25, Issue 29, 2006, Pages 4110-4115

  Bianchi, T ^a   Rufer, N ^b   MacDonald, H R ^a   Migliaccio, M ^b,c  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

^b Schweizerische Nationalfonds SNF   (Switzerland)

^c SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

Apoptosis; Cell stress; p16Ink4a; T lymphocyte

Indexed keywords

FAS ANTIGEN; PROTEIN P16INK4A; T LYMPHOCYTE RECEPTOR; CDKN2A PROTEIN, MOUSE; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN P14ARF;

ANIMAL CELL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CYCLE PROGRESSION; CELL DIVISION; CELL POPULATION; CELL SURVIVAL; CONTROLLED STUDY; GAMMA IRRADIATION; GENE FUNCTION; GENETIC REGULATION; LYMPHOID ORGAN; MITOSIS RATE; MOUSE; MOUSE STRAIN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SENSITIVITY ANALYSIS; SPLEEN; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THYMUS; TUMOR SUPPRESSOR GENE; WILD TYPE; ANIMAL; COMPARATIVE STUDY; CYTOLOGY; GAMMA RADIATION; GENETICS; IMMUNOLOGY; MOUSE MUTANT; ORGAN SIZE; PRENATAL DEVELOPMENT; RADIATION EXPOSURE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GAMMA RAYS; MICE; MICE, KNOCKOUT; ORGAN SIZE; OXIDATIVE STRESS; RECEPTORS, ANTIGEN, T-CELL; THYMUS GLAND; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 33745786808     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209437     Document Type: Article

References (29)

1. Al-Mohanna MA, Manogaran PS, Al-Mukhalafi Z, Al-Hussein KA, Aboussekhra A. (2004). Oncogene 23: 201-212.
2. Amstad PA, Liu H, Ichimiya M, Berezesky IK, Trump BF, Buhimschi IA et al. (2001). Redox Rep 6: 351-362.
3. Ashwell JD, Lu FW, Vacchio MS. (2000). Annu Rev Immunol 18: 309-345.
4. Azenabor AA, Hoffman-Goetz L. (1999). J Appl Physiol 86: 1823-1827.
5. Cayota A, Vuillier F, Gonzalez G, Dighiero G. (1996). Blood 87: 4746-4753.
6. Cemerski S, van Meerwijk JP, Romagnoli P. (2003). Eur J Immunol 33: 2178-2185.
7. Chazal M, Marionnet C, Michel L, Mollier K, Dazard JE, Della Valle V et al. (2002). Oncogene 21: 2652-2661.
8. Chen JH, Stoeber K, Kingsbury S, Ozanne SE, Williams GH, Hales CN. (2004). J Biol Chem 279: 49439-49446.
9. Cope AP. (2002). Arthritis Res 4(Suppl 3): S197-S211.
10. de Magalhaes JP, Chainiaux F, Remacle J, Toussaint O. (2002). FEBS Lett 523: 157-162.
11. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E et al. (1996). Cell 85: 733-744.
12. Franklin DS, Godfrey VL, Lee H, Kovalev GI, Schoonhoven R, Chen-Kiang S et al. (1998). Genes Dev 12: 2899-2911.
13. Hingorani R, Bi B, Dao T, Bae Y, Matsuzawa A, Crispe IN. (2000). J Immunol 164: 4032-4036.
14. Holler N, Tardivel A, Kovacsovics-Bankowski M, Hertig S, Gaide O, Martinon F et al. (2003). Mol Cell Biol 23: 1428-1440.
15. Kim HJ, Nel AE. (2005). J Immunol 175: 2948-2959.
16. Lagresle C, Gardie B, Eyquem S, Fasseu M, Vieville JC, Pla M et al. (2002). J Immunol 168: 2325-2331.
17. Lowe SW, Sherr CJ. (2003). Curr Opin Genet Dev 13: 77-83.
18. Malumbres M, Perez de Castro I, Santos J, Melendez B, Mangues R, Serrano M et al. (1997). Oncogene 14: 1361-1370.
19. Marrack P, Kappler J. (2004). Annu Rev Immunol 22: 765-787.
20. Migliaccio M, Raj K, Menzel O, Rufer N. (2005). J Immunol 174: 3335-3343.
21. Quadrilatero J, Hoffman-Goetz L. (2004). Biochem Biophys Res Commun 319: 894-901.
22. Remans PH, Gringhuis SI, van Laar JM, Sanders ME, Papendrecht-van der Voort EA, Zwartkruis FJ et al. (2004). J Immunol 173: 920-931.
23. Rodriguez-Mora OG, Howe CJ, Lahair MM, McCubrey JA, Franklin RA. (2005). Free Radic Biol Med 38: 1653-1661.
24. Roussel MF. (1999). Oncogene 18: 5311-5317.
25. Sachs Z, Sharpless NE, DePinho RA, Rosenberg N. (2004). J Virol 78: 3304-3311.
26. Serrano M, Blasco MA. (2001). Curr Opin Cell Biol 13: 748-753.
27. Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ et al. (2001). Nature 413: 86-91.
28. Voorhoeve PM, Agami R. (2003). Cancer Cell 4: 311-319.
29. Zindy F, Quelle DE, Roussel MF, Sherr CJ. (1997). Oncogene 15: 203-211.